Aileron Therapeutics Inc (NAS:ALRN)
$ 2.87 0.03 (1.06%) Market Cap: 61.96 Mil Enterprise Value: 44.70 Mil PE Ratio: 0 PB Ratio: 1.08 GF Score: 42/100

Aileron Therapeutics Inc M&A Call Transcript

Oct 31, 2023 / 05:30PM GMT
Release Date Price: $1.17 (-4.10%)
Operator

Good morning, and welcome to the Aileron Therapeutics conference call to discuss the acquisition of Lung Therapeutics. (Operator Instructions) Please be advised that this audio presentation is being recorded.

Now, I'd like to turn the call over to Susan Drexler, Chief Financial Officer of Aileron. Mr. Drexler?

Susan Drexler
Aileron Therapeutics, Inc. - Interim CFO

Thank you, operator, and good afternoon, everyone. Earlier today, we issued a press release that outlined our acquisition of Lung Therapeutics. This release is available at aileronrx.com under the Investors and Media tab.

Before we begin, I would like to remind everyone that statements made during this webcast relating to Aileron's expected future performance, future business prospects, or future events or plans may include forward-looking statements as defined under the Private Securities Litigation Reform Act of 1995. As such, forward-looking statements are intended to be subject to the Safe Harbor protection provided by the Reform Act.

Actual outcomes and results could

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot